UPDATE ON SCHIZOPHRENIA – Some second-generation antipsychotic medications are associated with substantially more metabolic side effects than other SGAs, according to a Cochrane analysis of 48 studies of schizophrenia (Rummel-Kluge et al. Schizophr Res 2010; 123: 225-233).
Recommend to a Colleague